© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
May 01, 2019
The Biosimilars Forum, in partnership with Medicines for Europe, says the U.S. can look to European policy directives to advance the biosimilars market.
April 15, 2019
The falsehoods being spread about biosimilars that don’t match up with reality.
April 01, 2019
The FDA issued a lengthy statement on biosimilar naming conventions-but industry groups worry it could disincentivize biosimilar development.
Industry groups are calling for clear FDA guidance on language used by biologic originators to protect market share.
What the future of specialty drugs holds for healthcare.
March 01, 2019
The latest in RA therapies, and what you can expect from the pipeline.
Biosimilar drugs are poised to transform the cancer drug market-so why is uptake so slow?
As more biosimilar agents are approved by the FDA, biologic manufacturers are looking for unique ways to hold on to market share.
February 06, 2019
While still largely a new phenomenon, biosimilars are here to stay-and this year will only bring more of them to market.
February 01, 2019
Biosimilar adoption is not happening as fast as once expected-will fears about future growth hold the market back?